Primary Job Title Founder and Chief Scientific Officer Primary Organization OCMS Bio
Location Philadelphia, Pennsylvania, United States Regions Greater Philadelphia Area, Great Lakes, Northeastern US Gender Male
LinkedIn View on LinkedIn X (Twitter) View on X
Scott Dessain is the Founder and the Chief Scientific Officer at Immunome. He is an Associate Professor at the Lankenau Institute for Medical Research, Wynnewood PA. He received M.D. and Ph.D. degrees from Yale University in 1994. He pursued post-graduate medical training in Internal Medicine at Brigham and Women’s Hospital, followed by a
fellowship in Medical Oncology at Dana Farber/Partners Cancer Care Boston, MA. His post-doctoral training was with Dr. Robert Weinberg at the Whitehead Institute in Cambridge, MA, at which time he devised novel techniques to efficiently clone native human antibodies. Following his fellowship, he spent 2 years as an instructor at the Massachusetts General Hospital in Boston, specializing in bone marrow transplantation and malignant hematology, and then joined the faculty of the Cardeza Foundation for Hematologic Research at the Thomas Jefferson University in Philadelphia. He co-founded Immunome in 2008. He has contributed to 29 published articles and two U.S. patents. Dr. Dessain has received K08 and R01 research grants from the National Institute of Health. He is Board-Certified in Medical Oncology and attends at the Lankenau Hospital in Wynnewood, PA.
